围术期药物干预对游离皮瓣移植术后并发血管危象的影响:一项回顾性队列研究

Effect of perioperative pharmacological intervention on postoperative vascular crisis in free flap transplantation: A retrospective cohort study

  • 摘要: 背景 血管危象是游离皮瓣移植术后的主要并发症,严重影响皮瓣存活,围术期关键药物的应用策略仍存在广泛争议。目的 探索血管加压药物、镇痛药物、抗凝药物和血管扩张药物对游离皮瓣移植术后并发血管危象的影响。方法 回顾性分析1996 年1 月至2024 年12 月在解放军总医院行游离皮瓣移植术修复组织缺损的患者资料,采用逆概率加权(inverse probability of treatment weighting,IPTW)法控制混杂偏倚,分别评估4 种药物对血管危象的影响,并采用Bonferroni法进行多重比较校正。结果 本研究共纳入323 例患者,其中男性194 例,女性129 例,平均年龄为(47.2 ± 15.8)岁,术后血管危象发生率为16.1%,皮瓣完全坏死率为5.0%。经IPTW调整后,各药物组与相应未用药组间协变量均达到良好平衡(标准化均数差standardized mean difference,SMD<0.1)。加权多因素logistic 回归分析显示,血管加压药物(OR=1.369,95% CI:0.746 ~ 2.505)、镇痛药物(OR=0.876,95% CI:0.447 ~ 1.659)、抗凝药物(OR=2.931,95% CI:0.941 ~ 13.470)及血管扩张药物(OR=0.990,95% CI:0.504 ~ 2.003)与血管危象的关联均无统计学意义,敏感性分析结果与主分析一致。结论 术中应用血管加压药物,术后应用镇痛药物、抗凝药物和血管扩张药物均不会对术后血管危象的发生产生影响。

     

    Abstract: Background Vascular crisis is a critical postoperative complication following free flap transplantation, posing a significant threat to flap survival. Despite its clinical significance, consensus on optimal perioperative pharmacological management remains lacking. Objective To evaluate the impact of vasopressors, analgesics, anticoagulants, and vasodilators on the occurrence of vascular crisis following free flap transplantation. Methods A retrospective analysis was conducted on patients who underwent free flap reconstruction for tissue defects at Chinese PLA General Hospital from January 1996 to December 2024. Confounding bias was adjusted by inverse probability of treatment weighting (IPTW), and the associations between four prophylactic agents and vascular crisis were assessed with Bonferroni-corrected multiple comparisons. Results A total of 323 patients (194 males and 129 females, mean age of 47.2±15.8 years) were included. The overall incidence of postoperative vascular crisis was 16.1%, with complete flap necrosis occurring in 5.0% of cases. Following IPTW, covariate balance was achieved across all exposure - nonexposure comparisons (standardized mean difference SMD < 0.1 for all variables). Weighted logistic regression revealed no statistically significant association between vascular crisis and vasopressor use (OR=1.369, 95% CI: 0.746 - 2.505), analgesic use (OR=0.876, 95% CI: 0.447 - 1.659), anticoagulant use (OR=2.931, 95% CI: 0.941 - 13.470), or vasodilator use (OR=0.990, 95% CI: 0.504 - 2.003). Sensitivity analyses yielded consistent results, supporting the robustness of the primary findings. Conclusion  Intraoperative vasopressors and postoperative analgesics, anticoagulants, and vasodilators show no impact on postoperative vascular crisis.

     

/

返回文章
返回